Israel finds no link between Pfizer Covid shot and stroke

Portfolio
Israel has not identified any evidence linking strokes to an updated coronavirus vaccine made by U.S. drugmaker Pfizer and its German partner BioNTech, according to a health ministry official, Reuters reported on Friday.
Pfizer oltás

Last Friday (13 Jan), the the U.S. Food and Drug Administration (FDA) and the Centres for Disease Control and Prevention (CDC) issued a joint statement claiming that the agencies were assessing data regarding Pfizer-BioNTech's COVID-19 vaccine bivalent increases the risk of ischemic stroke in elders.

We have not turned up such a finding, even after we went back and rechecked all our data after the FDA announcement,

said Salman Zarka, the head of Israel’s coronavirus task force said in a video briefing sent to Reuters on Thursday.

Some 389,648 people in Israel have so far taken the shot, which targets the original strain and its BA.4/BA.5 Omicron subvariant.

On Wednesday, the European Union’s drug regulator also said it had found no safety signals in the region related to Pfizer’s bivalent shot.

"EMA can confirm that to date no such signal has been identified in the EU. EMA will continue to evaluate all available data to determine whether emerging safety information could point to a similar signal in the EU," the agency told Reuters in response to a question.

Cover photo: Getty Images

 

More in Business

gáz
September 10, 2025 08:14

The European Union may sign a gigantic gas deal with the United States

Decades-long LNG agreements may be on the horizon

rába2
September 08, 2025 15:17

Attention, shareholders! This is what Hungary's 4iG has in store for Rába

Will the machine manufacturer remain on the stock exchange?

rába
September 08, 2025 10:05

Hungary 4iG to acquire majority stake in Rába

Gives HUF 1,789 per share offer to shareholders

September 04, 2025 16:11

Thyssenkrupp's international reorganisation to affect Hungary too

Company revamps structure

September 03, 2025 14:54

Chinese giant in Hungarian e-commerce: how can local businesses compete with Temu?

Here are some recommendations

uzsoki mate
September 03, 2025 12:00

EU’s new directive also affects Hungarian companies: how to prepare for NIS2

Interview with Máté Uzsoki, Managing Director of Serpentarius Software

LATEST NEWS
Charting is displayed using TradingView's technology, a platform, where you can build advanced charts, spot upcoming trends in the stock screener, and find inspiration in multiple trading ideas

Detailed search